April 21st/22nd – A historic moment for healthy longevity science
In Switzerland, the Swiss Campus for Healthy Longevity at the University of Basel hosted the first partner meeting of the Global Health Span Extension Consortium, a truly historic event for the future of healthy longevity science and translation.
This was more than a meeting. It was the launch of a new kind of global effort: one designed to connect the fields that too often work in parallel rather than together. What makes this consortium unique is its ability to bring together top scientists with complementary expertise across clinical care, public health, epidemiology, large cohort studies, randomized clinical trials, biology of aging, biomarkers, AI health, and health economics, all within one science-based platform focused on extending healthspan, not just preventing one disease.
This is also why the moment is so timely. The field of healthy longevity is advancing rapidly, with powerful new biomarkers, multi-omics tools, AI-enabled analytics, and growing global urgency to translate discoveries into meaningful benefits for people and populations. What is needed now is not more fragmentation, but integration, linking discovery science to clinical validation, implementation, and public health impact. That is exactly the role this consortium aims to play.
A defining strength of this consortium is its healthspan-first lens. The shared ambition is not to focus narrowly on one disease area, but to advance overall health, function, resilience, cognition, and wellbeing across the lifespan. The consortium also stands out because it creates a rare translational “engine” between cohorts and trials, allowing observational data to inform interventions, and trials to validate biomarkers and feed findings back into population science. This two-way model has the potential to accelerate discovery and translation in ways that individual efforts cannot achieve alone.
We are deeply grateful to Prof. Andrea Schwenker-Wicki, President of the University of Basel, for her inspiring speech to the consortium, and to Prof. Primo Schär, Vice President of the University of Basel, for opening the scientific sessions and underscoring the central importance of evidence in longevity science — a principle at the heart of this consortium and one with relevance to everyone.
We also extend our sincere thanks to Sebastien Thuault, Editor of Nature Aging, who attended both days of the meeting and led a key panel on the consortium’s next steps. His presence and engagement reinforced the importance of building this field with rigor, clarity, and scientific ambition.
A special thank you also to our keynote speakers, Prof. Steve Horvath and Prof. Tony Wyss-Coray, who coordinate this consortium together with Prof. Heike A. Bischoff-Ferrari, Prof. Joanne Ryan and Prof. Walter Willett. The presentations of Prof. Horvath and Prof. Wyss-Coray helped frame both the scientific depth and translational promise of this new and unique global collaboration.
What stood out throughout these two days was a shared commitment to rigorous, evidence-based science collaboration and a clear determination to accelerate the translation of novel measures of biological aging and multimodal treatments that extend health span into real-world scalable public health benefits. This consortium has the potential to help move healthy longevity from promise to practice.
The work starts now.